Dr. Nitin Kitchley Egbert, MD

Dr. Egbert practices at UCSF St Mary's Hospital in San Francisco, California.

Dr. Egbert's NPI, 1922501741, was assigned on March 18, 2018. Dr. Egbert graduated from Ohio State College of Medicine in 2018. Dr. Egbert holds California license A181929.

Dr. Egbert's primary practice is UCSF St Mary's Hospital, at 450 Stanyan St, San Francisco, CA 94117 in San Francisco County. The practice phone is (415) 353-4739.

Dr. Egbert's primary practice is UCSF St Mary's Hospital in San Francisco, California. Dr. Egbert is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Egbert to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Egbert practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Egbert's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Egbert is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Egbert's licenses on file in 2 states: California and Nevada.

Dmand AI lists anemia, bile duct problems, dementia, electrolyte disorders, gastrointestinal inflammation, pneumonia and respiratory infection, pulmonary embolism and sepsis among the conditions Dr. Egbert treats.

CMS data shows 509 Medicare services from Dr. Egbert across 5 procedure codes in 2024, for 171 Medicare patients. Medicare paid $46,771 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Egbert in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Egbert's median patient age at 71, with 45% women.

In 2024, Dr. Egbert wrote 144 Medicare Part D claims for 53 patients. 83% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $73 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Egbert for performance year 2024, reported as part of a group. Dr. Egbert accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Egbert, published from 2014 to 2019. Dr. Egbert's most frequent co-authors are Annick Paulin Aubin-Pouliot, Mina Samir Makary, MD and Luciano M. Prevedello, MD.

CMS Open Payments shows 9 general payments to Dr. Egbert from 5 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $48.

Dr. Egbert graduated from Ohio State College of Medicine in 2018.

Dr. Egbert is in network with 4 carriers, including Aetna, CMS Medicare and Molina. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.